CoChat

Improving antivenom availability and accessibility: Science, technology, and beyond

Gutiérrez, José María · 2012 · Toxicon
Cited by 104

The DOI matches its Crossref record.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.toxicon.2012.02.008

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 67

  1. Abubakar, 2010, Pre-clinical and preliminary dose-finding and safety studies to identify candidate antivenoms for treatment of envenoming by saw-scale or carpet vipers (Echis ocellatus) in northern Nigeria, Toxicon, 55, 719, 10.1016/j.toxicon.2009.10.024 · doi:10.1016/j.toxicon.2009.10.024
  2. Abubakar, 2010, Randomised controlled double-blind non-inferiority trial of two antivenoms for saw-scale or carpet viper (Echis ocellatus) envenoming in Nigeria, PLoS Negl. Trop. Dis., 4, e767, 10.1371/journal.pntd.0000767 · DOI
  3. Abubakar, 2010, Amputation and disability following snakebite in Nigeria, Trop. Doct., 40, 114, 10.1258/td.2009.090266 · doi:10.1258/td.2009.090266
  4. Alape-Girón, 2008, Snake venomics of the lancehead pitviper Bothrops asper: geographic, individual, and ontogenetic variations, J. Proteome Res., 7, 3556, 10.1021/pr800332p · DOI · Paper page
  5. Alirol, 2010, Snake bite in South Asia: a review, PLoS Negl. Trop. Dis., 4, e603, 10.1371/journal.pntd.0000603 · DOI · Paper page
  6. Arroyo, 1999, Envenenamiento por mordedura de serpiente en Costa Rica en 1996: epidemiología y consideraciones clínicas, Acta Médica Costarricense, 41, 23, 10.51481/amc.v41i4.528 · doi:10.51481/amc.v41i4.528
  7. Burnouf, 2004, Assessment of the viral safety of antivenoms fractionated from equine plasma, Biologicals, 32, 115, 10.1016/j.biologicals.2004.07.001 · DOI
  8. Calvete, 2011, Proteomic tools against the neglected pathology of snake bite envenoming, Expert Rev. Proteomics, 8, 739, 10.1586/epr.11.61 · DOI · Paper page
  9. Calvete, 2010, Antivenomic assessment of the immunological reactivity of EchiTAb-Plus-ICP, an antivenom for the treatment of snakebite envenoming in sub-Saharan Africa, Am. J. Trop. Med. Hyg., 82, 1194, 10.4269/ajtmh.2010.09-0733 · DOI
  10. Cardoso, 1993, Randomized comparative trial of three antivenoms in the treatment of envenoming by lance-headed vipers (Bothrops jararaca) in São Paulo, Brazil. Q. J. Med., 86, 315
  11. Chippaux, 1998, Snake-bites: appraisal of the global situation, Bull. World Health Organ., 76, 515
  12. Chippaux, 2011, Estimate of the burden of snakebites in sub-Saharan Africa: a meta-analytic approach, Toxicon, 57, 588, 10.1016/j.toxicon.2010.12.022 · DOI
  13. Chippaux, 1998, Clinical safety of a polyvalent F(ab′)2 equine antivenom in 223 African snake envenomations: a field trial in Cameroon, Trans. R. Soc. Trop. Med. Hyg., 92, 657, 10.1016/S0035-9203(98)90802-1 · doi:10.1016/s0035-9203(98)90802-1
  14. Chippaux, 2007, Clinical trial of an F(ab′)2 polyvalent equine antivenom for African snake bites in Benin, Am. J. Trop. Med. Hyg., 77, 538, 10.4269/ajtmh.2007.77.538 · DOI
  15. Chippaux, 1991, Snake venom variability: methods of study, results and interpretation, Toxicon, 29, 1279, 10.1016/0041-0101(91)90116-9 · DOI · Paper page
  16. Guidolin, 2010, Polyvalent horse F(ab′)2 snake antivenom: development of process to produce polyvalent horse F(ab′)2 antibodies anti-African snake venom, African J. Biotechnol., 9, 2446
  17. Gutiérrez, 2011, Envenenamientos por mordeduras de serpientes en América Latina y el Caribe: Una visión integral de carácter regional, Bol. Malariol. Salud Ambiental, 51, 1
  18. Gutiérrez, J.M., in press. Snakebite envenoming: a public health perspective. In: Maddock, J. (Ed.), Public Health: Epidemiology, Environmental and System Issues. Intech, Croatia.
  19. Gutiérrez, 2009, Stability, distribution and use of antivenoms for snakebite envenomation in Latin America: report of a workshop, Toxicon, 53, 625, 10.1016/j.toxicon.2009.01.020 · doi:10.1016/j.toxicon.2009.01.020
  20. Gutiérrez, 2007, Strengthening antivenom production in Central and South American public laboratories: report of a workshop, Toxicon, 49, 30, 10.1016/j.toxicon.2006.09.005 · doi:10.1016/j.toxicon.2006.09.005
  21. Gutiérrez, 2011, Antivenoms for the treatment of snakebite envenomings: the road ahead, Biologicals, 39, 129, 10.1016/j.biologicals.2011.02.005 · DOI · Paper page
  22. Gutiérrez, 2009, Snake venomics and antivenomics: proteomic tools in the design and control of antivenoms for the treatment of snakebite envenoming, J. Proteomics, 72, 165, 10.1016/j.jprot.2009.01.008 · DOI · Paper page
  23. Gutiérrez, 2005, Pan-African polyspecific antivenom produced by caprylic acid purification of horse IgG: an alternative to the antivenom crisis in Africa, Trans. R. Soc. Trop. Med. Hyg., 99, 468, 10.1016/j.trstmh.2004.09.014 · doi:10.1016/j.trstmh.2004.09.014
  24. Gutiérrez, 2006, Confronting the neglected problem of snake bite envenoming: the need for a global partnership, PLoS Med., 3, e150, 10.1371/journal.pmed.0030150 · DOI · Paper page
  25. Gutiérrez, 2010, Snakebite envenoming from a global perspective: towards an integrated approach, Toxicon, 56, 1223, 10.1016/j.toxicon.2009.11.020 · DOI · Paper page
  26. Habib, 2001, Snake bite in Nigeria, African J. Med. Med. Sci., 30, 171
  27. Hansson, 2010, Mapping snakebite epidemiology in Nicaragua. Pitfalls and possible solutions, PLoS Negl. Trop. Dis., 4, e896, 10.1371/journal.pntd.0000896 · doi:10.1371/journal.pntd.0000896
  28. Harrison, 2009, Snakebite envenoming: a disease of poverty, PLoS Negl. Trop. Dis., 3, e569, 10.1371/journal.pntd.0000569 · DOI · Paper page
  29. Hasan, 2012, The impact of snake bite on household economy in Bangladesh, Trop. Doct., 42, 41, 10.1258/td.2011.110137 · doi:10.1258/td.2011.110137
  30. Ho, 2011, Economical value of vaccines for the developing countries-The case of Instituto Butantan, a public institution in Brazil, PLoS Negl. Trop. Dis., 5, e1300, 10.1371/journal.pntd.0001300 · doi:10.1371/journal.pntd.0001300
  31. Hotez, 2007, Control of neglected tropical diseases, N. Engl. J. Med., 357, 1018, 10.1056/NEJMra064142 · DOI · Paper page
  32. Jiménez-Porras, 1964, Intraspecific variations in composition of venom of the jumping viper, Bothrops numifera, Toxicon, 2, 187, 10.1016/0041-0101(64)90021-2 · doi:10.1016/0041-0101(64)90021-2
  33. Kasturiratne, 2008, The global burden of snakebite: a literature analysis and modelling base don regional estimates of envenoming and deaths, PLoS Med., 5, e218, 10.1371/journal.pmed.0050218 · DOI · Paper page
  34. Lalloo, 1995, Snake bites by the Papuan taipan (Oxyuranus scutellatus canni): paralysis, hemostatic and electrocardiographic abnormalities, and effects of antivenom, Am. J. Trop. Med. Hyg., 52, 525, 10.4269/ajtmh.1995.52.525 · doi:10.4269/ajtmh.1995.52.525
  35. Leynaud, 2009, Identificación de las zonas de riesgo ofídico en Córdoba, Argentina, mediante el programa SIGEpi, Rev. Panam. Salud Pública, 26, 64, 10.1590/S1020-49892009000700010 · doi:10.1590/s1020-49892009000700010
  36. Lomonte, 2008, Snake venomics and antivenomics of the arboreal neotropical pitvipers Bothriechis lateralis and Bothriechis schlegelii, J. Proteome Res., 7, 2445, 10.1021/pr8000139 · DOI
  37. Méndez, 2011, Comparative study of the cytolytic activity of snake venoms from African spitting cobras (Naja spp, Elapidae) and its neutralization by a polyspecific antivenom, Toxicon, 58, 558, 10.1016/j.toxicon.2011.08.018 · DOI
  38. Michael, 2010, The effect of pre-hospital care for venomous snake bite on outcome in Nigeria, Trans. R. Soc. Trop. Med. Hyg., 105, 95, 10.1016/j.trstmh.2010.09.005 · doi:10.1016/j.trstmh.2010.09.005
  39. Mohapatra, 2011, Snakebite mortality in India: a nationally representative mortality survey, PLoS Negl. Trop. Dis., 5, e1018, 10.1371/journal.pntd.0001018 · DOI · Paper page
  40. Morel, 2005, Health innovation networks to help developing countries address neglected diseases, Science, 309, 401, 10.1126/science.1115538 · DOI · Paper page
  41. Moreno, 2011, The struggle of neglected scientific groups: ten years of NeTropica efforts to promote research in tropical diseases in Central America, PLoS Negl. Trop. Dis., 5, e1055, 10.1371/journal.pntd.0001055 · doi:10.1371/journal.pntd.0001055
  42. Otero, 2000, Snakebites and ethnobotany in the northwestern region of Colombia: Part I: Traditional use of plants, J. Ethnopharmacol., 71, 493, 10.1016/S0378-8741(00)00243-9 · DOI
  43. Petras, 2011, Snake venomics of African spitting cobras: toxin composition and assessment of congeneric cross-reactivity of the pan-African EchiTAb-Plus-ICP antivenom by antivenomics and neutralization approaches, J. Proteome Res., 10, 1266, 10.1021/pr101040f · DOI · Paper page
  44. Prasad, 1999, Comparative characterization of Russell's viper (Daboia/Vipera russelli) venoms from different regions of the Indian peninsula, Biochim. Biophys. Acta, 1428, 121, 10.1016/S0304-4165(99)00053-7 · DOI
  45. Pugh, 1980, Incidence and mortality on snake bite in savanna Nigeria, Lancet, 2, 1181, 10.1016/S0140-6736(80)92608-2 · doi:10.1016/s0140-6736(80)92608-2
  46. Rahman, 2010, Annual incidence of snake bite in rural Bangladesh, PLoS Negl. Trop. Dis., 4, e860, 10.1371/journal.pntd.0000860 · doi:10.1371/journal.pntd.0000860
  47. Ramos-Cerrillo, 2008, Characterization of a new polyvalent antivenom (Antivipmyn Africa) against African vipers and elapids, Toxicon, 52, 881, 10.1016/j.toxicon.2008.09.002 · doi:10.1016/j.toxicon.2008.09.002
  48. Rodrigues-Silva, 1999, Thermal stability studies of hyperimmune horse antivenoms, Toxicon, 37, 33, 10.1016/S0041-0101(97)00101-3 · doi:10.1016/s0041-0101(97)00101-3
  49. Segura, 2010, Preclinical assessment of the neutralizing capacity of antivenoms produced in six Latin American countries against medically-relevant Bothrops snake venoms, Toxicon, 56, 980, 10.1016/j.toxicon.2010.07.001 · DOI
  50. Segura, 2009, Stability of equine IgG antivenoms obtained by caprylic acid precipitation: towards a liquid formulation stable at tropical room temperature, Toxicon, 53, 609, 10.1016/j.toxicon.2009.01.012 · doi:10.1016/j.toxicon.2009.01.012
  51. Segura, 2010, Preclinical assessment of the efficacy of a new antivenom (EchiTAb-Plus-ICP) for the treatment of viper envenoming in sub-Saharan Africa, Toxicon, 55, 369, 10.1016/j.toxicon.2009.08.010 · DOI
  52. Sharma, 2004, Impact of snake bites and determinants of fatal outcomes in southeastern Nepal, Am. J. Trop. Med. Hyg., 21, 234, 10.4269/ajtmh.2004.71.234 · doi:10.4269/ajtmh.2004.71.234
  53. Simpson, 2008, A study of the current knowledge base in treating snake bite amongst doctors in the high-risk countries of India and Pakistan: does snake bite treatment training reflect local requirements?, Trans. R. Soc. Trop. Med. Hyg., 102, 1108, 10.1016/j.trstmh.2008.04.013 · DOI
  54. Snow, 1994, The prevalence and morbidity of snake bite and treatment-seeking behaviour among a rural Kenyan population, Ann. Trop. Med. Parasitol., 88, 665, 10.1080/00034983.1994.11812919 · doi:10.1080/00034983.1994.11812919
  55. Stock, 2007, Bringing antivenoms to sub-Saharan Africa, Nat. Biotechnol., 25, 173, 10.1038/nbt0207-173 · doi:10.1038/nbt0207-173
  56. Swaroop, 1954, Snakebite mortality in the world, Bull. World Health Organ., 10, 35
  57. Theakston, 1983, Development of simple standard assay procedures for the characterization of snake venom, Bull. World Health Organ., 61, 949
  58. Theakston, 2000, Crisis in snake antivenom supply for Africa, Lancet, 356, 2104, 10.1016/S0140-6736(05)74319-1 · DOI · Paper page
  59. Theakston, 2003, Report of a WHO workshop on the standardization and control of antivenoms, Toxicon, 41, 541, 10.1016/S0041-0101(02)00393-8 · DOI · Paper page
  60. Trape, 2001, High mortality from snakebite in south-eastern Senegal, Trans. R. Soc. Trop. Med. Hyg., 95, 420, 10.1016/S0035-9203(01)90202-0 · doi:10.1016/s0035-9203(01)90202-0
  61. Vargas, 2011, Preclinical evaluation of caprylic acid-fractionated IgG antivenom for the treatment of Taipan (Oxyuranus scutellatus) envenoming in Papua New Guinea, PLoS Negl. Trop. Dis., 5, e1144, 10.1371/journal.pntd.0001144 · doi:10.1371/journal.pntd.0001144
  62. Visser, 2008, Failure of a new antivenom to treat Echis ocellatus snake bite in rural Ghana: the importance of quality surveillance, Trans. R. Soc. Trop. Med. Hyg., 102, 445, 10.1016/j.trstmh.2007.11.006 · DOI
  63. Warrell, 2008, Unscrupulous marketing of snake bite antivenoms in Africa and Papua New Guinea: choosing the right product-‘what’s in a name?’, Trans. R. Soc. Trop. Med. Hyg., 102, 397, 10.1016/j.trstmh.2007.12.005 · doi:10.1016/j.trstmh.2007.12.005
  64. Warrell, 2010, Snake bite, Lancet, 375, 77, 10.1016/S0140-6736(09)61754-2 · DOI · Paper page
  65. Williams, 2010, The Global Snake Bite Initiative: an antidote for snake bite, Lancet, 375, 89, 10.1016/S0140-6736(09)61159-4 · DOI · Paper page
  66. Williams, 2011, Ending the drought: new strategies for improving the flow of affordable, effective antivenoms in Asia and Africa, J. Proteomics, 74, 1735, 10.1016/j.jprot.2011.05.027 · DOI · Paper page
  67. Williams, 2011, Delayed psychological morbidity associated with snakebite envenoming, PLoS Negl. Trop. Dis., 5, e1255, 10.1371/journal.pntd.0001255 · DOI

Cited by

Metadata

Authors
Gutiérrez, J. M.
Venue
Toxicon
Publisher
Elsevier BV
Published
2012-09
Volume
60
Issue
4
Pages
676-687
ISSN
0041-0101
Cited by
104
References
0
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
  • Vicerrectoría de Investigación (Universidad de Costa Rica)
  • CONARE
  • Fundación CRUSA
  • NeTropica
  • CYTED

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.